| 2004 |
HKE4 (SLC39A7/ZIP7) localizes to intracellular membranes including the endoplasmic reticulum and increases intracellular free zinc in a time-, temperature-, and concentration-dependent manner, as measured by the zinc-specific fluorescent dye Newport Green. The protein contains a conserved HEXPHEXGD metalloprotease motif in transmembrane domain V and a consensus zinc-transport sequence in transmembrane domain IV. |
Transient expression in mammalian cells, fluorescent zinc dye (Newport Green), immunolocalization |
The Biochemical journal |
Medium |
14525538
|
| 2005 |
Endogenous ZIP7 associates with the Golgi apparatus and transports zinc from the Golgi into the cytoplasm. In a yeast Δzrt3 mutant defective in vacuolar zinc release, ZIP7 expression decreased accumulated vacuolar zinc and increased nuclear/cytoplasmic labile zinc. ZIP7 protein expression is repressed under zinc-rich conditions but its intracellular localization is unaffected by zinc status. |
Subcellular fractionation, immunolocalization in CHO cells, yeast complementation assay (Δzrt3), V5-tagged overexpression |
The Journal of biological chemistry |
High |
15705588
|
| 2008 |
ZIP7 knockdown (siRNA) in tamoxifen-resistant MCF7 (TamR) breast cancer cells reduces intracellular zinc levels and abolishes activation of EGFR, IGF-IR, Src, HER2, HER3, and HER4, demonstrating that ZIP7-mediated zinc redistribution from intracellular stores to the cytoplasm is required for zinc-induced phosphatase inhibition and downstream growth factor receptor activation. |
siRNA knockdown, western blot for receptor phosphorylation, intracellular zinc measurement |
Endocrinology |
Medium |
18583420
|
| 2012 |
Protein kinase CK2 phosphorylates evolutionarily conserved residues in ZIP7 on the endoplasmic reticulum, triggering gated release of Zn2+ from ER stores into the cytosol, which activates tyrosine kinases and phosphorylation of AKT and ERK1/2. CK2 was identified as the responsible kinase by pharmacological inhibition, proximity ligation assay, and site-directed mutagenesis of the phosphorylation sites. |
Proximity ligation assay, pharmacological CK2 inhibition, site-directed mutagenesis, phospho-western blot, intracellular zinc imaging |
Science signaling |
High |
22317921
|
| 2012 |
Morpholino-mediated knockdown of zip7 in zebrafish causes morphological defects (reduced head size, smaller eyes, shorter palates, curved spinal cord) accompanied by reduced zinc concentrations in brain, eyes, and gills as measured by synchrotron radiation X-ray fluorescence, and these defects are partially rescued by zinc supplementation, establishing an in vivo requirement for Zip7 in developmental zinc homeostasis. |
Morpholino antisense knockdown in zebrafish, synchrotron radiation X-ray fluorescence (SR-XRF), zinc rescue experiment |
PloS one |
Medium |
22912764
|
| 2013 |
In Drosophila, loss of Catsup (the ZIP7 ortholog) causes Notch receptor to accumulate abnormally in the ER and Golgi, impairing Notch signaling, and elevates ER stress, linking ZIP7-dependent zinc homeostasis to secretory pathway protein trafficking and Notch receptor processing. |
Forward genetic screen, immunofluorescence localization of Notch in mutant epithelia, ER stress markers |
Development (Cambridge, England) |
Medium |
23785054
|
| 2013 |
siRNA knockdown of Zip7 in skeletal muscle cells downregulates expression of glucose metabolism genes (including Glut4, Insr, Irs1, Irs2) and reduces insulin-stimulated glycogen synthesis and AKT phosphorylation, placing ZIP7 upstream of insulin signaling and glucose uptake in skeletal muscle. |
siRNA knockdown, RT-PCR, western blot, glycogen synthesis assay, phospho-AKT immunoblot |
PloS one |
Medium |
24265765
|
| 2014 |
ZIP7 co-localizes with CLN6 (a disease-associated protein) at the ER/Golgi in neurons and astrocytes. Loss of Zip7 accompanies aberrant biometal accumulation in CLN6-variant NCL, and treatment with ZnII(atsm) upregulates Zip7, promotes zinc redistribution, and restores zinc-dependent functions in Cln6-deficient mouse neurons and astrocytes. |
Immunofluorescence co-localization, metal analysis, pharmacological rescue (ZnII(atsm)) in primary mouse neurons |
Acta neuropathologica communications |
Medium |
24581221
|
| 2016 |
Intestinal epithelium-specific knockout of Zip7 in mice triggers ER stress in proliferative progenitor cells, causes cell death of progenitors, loss of Olfm4+ intestinal stem cells, and degeneration of Paneth cells, establishing ZIP7 as essential for intestinal epithelial homeostasis through maintenance of ER function. |
Conditional knockout mouse (intestinal epithelium-specific), histology, immunofluorescence, ER stress markers |
PLoS genetics |
High |
27736879
|
| 2017 |
Site-directed mutagenesis of ZIP7 phosphorylation sites (S275, S276, and two additional predicted sites) demonstrates that all four residues are required for maximal ZIP7 activation and zinc release from intracellular stores. Phospho-protein arrays identify MAPK, mTOR, and PI3K-AKT as major downstream pathways activated by ZIP7-mediated zinc release. |
Site-directed mutagenesis, phospho-protein arrays, intracellular zinc imaging |
Metallomics : integrated biometal science |
High |
28205653
|
| 2017 |
ZIP7 ablation in collagen 1-expressing mesenchymal stem cells causes dermal dysplasia in mice. Loss of ZIP7 causes zinc accumulation in the ER, leading to zinc-dependent aggregation and inhibition of protein disulfide isomerase (PDI), resulting in ER dysfunction and impaired cell proliferation. |
Conditional knockout mouse (mesenchymal), subcellular zinc measurement, PDI aggregation/activity assay, histology |
The Journal of investigative dermatology |
High |
28545780
|
| 2017 |
In hyperglycemic cardiomyocytes, ZIP7 is phosphorylated (CK2α-dependent) and redistributes cytosolic free Zn2+ from the ER to the cytosol as shown by FRET-based Zn2+ sensors. siRNA silencing of CK2α suppresses this redistribution. ZIP7 and ZnT7 are also localized to the sarco(endo)plasmic reticulum in cardiomyocytes by fractionation. |
FRET-based Zn2+ sensors, siRNA knockdown of CK2α, subcellular fractionation, phospho-western blot |
Diabetes |
High |
28232492
|
| 2018 |
Genetic ablation of SLC39A7 decreases cytosolic zinc, increases ER zinc levels, impairs cell proliferation, and induces ER stress. Increasing cytosolic zinc rescues both the ER stress and impaired proliferation, confirming impaired zinc transport as the causal mechanism. |
Genetic ablation (KO), intracellular zinc measurement, ER stress markers, proliferation assay, zinc supplementation rescue |
Molecular pharmacology |
High |
29980658
|
| 2018 |
ZIP7 and ZnT7 are localized to both the sarco(endo)plasmic reticulum and mitochondria in cardiomyocytes, as confirmed by fluorescence imaging and biochemical fractionation. In hyperglycemic cells, ZIP7 is decreased and ZnT7 is increased in mitochondrial fractions, associated with elevated mitochondrial Zn2+, increased ROS, and altered S(E)R-mitochondria coupling proteins. |
Fluorescence microscopy, subcellular fractionation, western blot of mitochondrial fractions, ROS measurement |
Mitochondrion |
Medium |
29307859
|
| 2018 |
Zinc promotes myoblast proliferation and differentiation via ZIP7-mediated activation of the PI3K/AKT pathway. siRNA depletion of ZIP7 reduces PI3K/AKT signaling and significantly reduces multinucleated myofibre and myotube formation. |
siRNA knockdown, western blot for pAKT, multinucleation assay |
Scientific reports |
Medium |
30206294
|
| 2018 |
Loss-of-function genetic screens in haploid human KBM7 (FADD-deficient) cells identify SLC39A7 knockout as conferring necroptosis resistance by reducing TNFR1 surface levels. SLC-focused CRISPR screens show specificity for TNFR1- and FAS-mediated but not TRAIL-R1-mediated pathways. Mechanistically, SLC39A7 loss augments ER stress and impairs receptor trafficking. |
Genome-wide gene-trap screens, CRISPR/Cas9 KO, flow cytometry for surface receptor levels, cell death assays |
Cell death and differentiation |
High |
30237509
|
| 2019 |
Hypomorphic mutations in SLC39A7 in humans cause a block in B cell development resulting in absent B cells and agammaglobulinemia. CRISPR-Cas9 modeling in mice reproduced the B cell developmental block. B cells from mutant mice showed diminished cytoplasmic free zinc, increased phosphatase activity, and decreased phosphorylation of pre-B cell receptor and B cell receptor signaling molecules, establishing ZIP7 as a modulator of BCR signal strength via cytosolic Zn2+. |
Human genetics (autosomal recessive mutations), CRISPR-Cas9 mouse modeling, flow cytometry, phosphatase activity assay, phospho-western blot, intracellular zinc measurement |
Nature immunology |
High |
30718914
|
| 2019 |
A phenotypic screen identified compounds that impair Notch trafficking and induce ER stress-mediated apoptosis via ZIP7. A compound-resistant cell line harbored a V430E mutation in ZIP7, conferring transferable resistance. An analog of the compound NVS-ZP7-4 photoaffinity-labeled ZIP7 in cells, indicating direct compound-ZIP7 interaction. NVS-ZP7-4 alters zinc levels in the ER. |
Phenotypic screen, drug-resistance mutation sequencing, photoaffinity labeling in cells, ER zinc measurement |
Nature chemical biology |
High |
30643281
|
| 2019 |
ZIP7 localized on the ER is distinct from ZIP13 (which localizes to both ER and Golgi when co-expressed). ZIP7 depletion induces ER stress in mesenchymal stem cells inhibiting fibrogenic differentiation, whereas ZIP13 depletion does not induce ER stress, establishing non-redundant, compartment-specific roles for each transporter. |
Conditional co-expression, immunofluorescence localization, ER stress markers, differentiation assay |
International journal of molecular sciences |
Medium |
31412620
|
| 2021 |
ZIP7 controls zinc transport from the ER to the cytosol and is required for ferroptosis in breast and renal cancer cells. Genetic or chemical inhibition of ZIP7 protects cells against ferroptosis; this protection is abolished by zinc supplementation. ZIP7 knockdown triggers ER stress including induction of HERPUD1 and ATF3, and knockdown of HERPUD1 abolishes the ferroptosis protection from ZIP7 inhibition, placing ZIP7 upstream of HERPUD1 in ferroptosis regulation. |
Genome-wide RNAi screen, siRNA knockdown, zinc supplementation rescue, ER stress marker induction, HERPUD1 knockdown epistasis |
Cell death & disease |
High |
33608508
|
| 2023 |
NLRX1 physically interacts with SLC39A7 (ZIP7) and forms an NLRX1-SLC39A7 complex on the mitochondrial membrane of nucleus pulposus cells, modulating mitochondrial Zn2+ trafficking to orchestrate mitochondrial dynamics (DNM1L/DRP1, OPA1, OMA1) and mitophagy. |
Co-immunoprecipitation, mitochondrial fractionation, FRET/zinc sensors, mitophagy assays (mito-LC3II, mitoKeima), animal and in vitro models |
Autophagy |
Medium |
37876250
|
| 2024 |
ZIP7 overexpression in Drosophila enhances ERAD by supplying Zn2+ to the Rpn11 Zn2+ metalloproteinase in the proteasome lid, facilitating deubiquitination of client proteins. In human cells, ZIP7 and cytosolic Zn2+ are rate-limiting for this deubiquitination step. ZIP7 overexpression in a Drosophila model of neurodegeneration (misfolded rhodopsin) degrades misfolded Rh1 and rescues photoreceptor viability and vision. |
Drosophila border cell migration genetics, proteasome deubiquitination assay, human cell Zn2+ manipulation, in vivo neurodegeneration model (rhodopsin misfolding) |
Developmental cell |
High |
38670102
|
| 2024 |
In diabetic cardiomyopathy (T2DM mouse model), ZIP7 is upregulated and mediates suppression of mitophagy via inhibition of the PINK1/Parkin pathway. ZIP7 cardiac-specific knockout (CRISPR-generated) prevents mitochondrial Zn2+ reduction, mitochondrial hyperpolarization, impaired PINK1/Parkin accumulation, and restores mitophagy, preventing cardiac dysfunction and fibrosis. |
CRISPR/Cas9 cardiac-specific KO mouse, echocardiography, mito-LC3II/mitoKeima/mitoQC mitophagy assays, DHE/mitoB ROS detection, mitochondrial Zn2+ measurement |
Cardiovascular diabetology |
High |
39511569
|
| 2024 |
ACSL4 interacts with ZIP7 and VDAC3 in mouse liver and human hepatocytes, forming a complex at ER-mitochondria contact sites. Inhibition of ZIP7 reduces mitochondrial iron overload while elevating ER iron, and inhibition of ACSL4 reduces the ZIP7-VDAC3 interaction, implicating an ACSL4-ZIP7-VDAC3 axis in ER-to-mitochondria iron transfer under PFOS exposure. |
Co-immunoprecipitation, siRNA/inhibitor knockdown of ZIP7/VDAC3/ACSL4, organellar iron measurement, mouse liver model |
The Science of the total environment |
Medium |
39579909
|
| 2025 |
METTL9 methylates SLC39A7 at His45 and His49 residues (N1-histidine methylation), suppressing ferroptosis through the ER stress PERK/ATF4 pathway and downstream SLC7A11-mediated glutathione synthesis, and inhibiting adipogenic differentiation of mesenchymal stem cells. |
Methyltransferase assay (METTL9), site-specific methylation mapping (His45, His49), ferroptosis assay, ROS measurement, PERK/ATF4/SLC7A11 western blot, adipogenic differentiation assay in vitro and OVX mouse model |
Molecular medicine (Cambridge, Mass.) |
Medium |
40414869
|
| 2024 |
ZIP7 interacts with the transcription factor MAZ in the cytoplasm and facilitates its nuclear import. Nuclear MAZ promotes MYBL2 transcription, driving prostate cancer bone metastasis. ZIP7 silencing inhibits PCa cell migration/invasion in vitro and bone metastasis in vivo. |
Co-immunoprecipitation, nuclear/cytoplasmic fractionation, RNA-seq, in vivo intra-arterial bone metastasis xenograft model, siRNA/inhibitor |
Communications biology |
Medium |
42010154
|